Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 5Lymphoid 3Genitourinary 3Gastrointestinal 3CNS 3Myeloid 2Gynecologic 1Dermatologic 1

Conditions

Ovarian Neoplasms 33Fallopian Tube Neoplasms 21Endometrial Neoplasms 17Uterine Cervical Neoplasms 13Colorectal Neoplasms 12Neoplasm Metastasis 10Pancreatic Neoplasms 9Prostatic Neoplasms 8Melanoma 8Lung Neoplasms 8Carcinoma, Renal Cell 7Stomach Neoplasms 6Carcinosarcoma 6Carcinoma, Hepatocellular 6Carcinoma, Transitional Cell 5Carcinoma, Non-Small-Cell Lung 5Breast Neoplasms 5Triple Negative Breast Neoplasms 4Papillomavirus Infections 4Esophageal Neoplasms 4Sarcoma 3Rectal Neoplasms 3Colonic Neoplasms 3Vulvar Neoplasms 2Urinary Bladder Neoplasms 2Thyroid Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Small Cell Lung Carcinoma 2Sarcoma, Kaposi 2Pelvic Neoplasms 2

Interventions

talazoparib 1X-Rays 1Thiotepa 1Specimen Handling 1Phantoms, Imaging 1Peripheral Blood Stem Cell Transplantation 1Melphalan 1Imatinib Mesylate 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1FANG vaccine 1Cyproheptadine 1Busulfan 1Bone Marrow Transplantation 1Bone Density 1Blood Specimen Collection 1Amifostine 1Absorptiometry, Photon 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma, Ewing × Specimen Handling × Gynecologic × Clear all
NCT04851119 2026-05-05

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Children's Oncology Group

Phase 1/2 Recruiting
147 enrolled
CNSDermatologicGastrointestinalGenitourinaryGynecologicLymphoidSarcoma

Carcinoma, Hepatocellular, Lymphoma, Non-Hodgkin, Melanoma, Wilms Tumor, Neuroblastoma, Ovarian Neoplasms, Sarcoma, Ewing, Osteosarcoma, Colorectal Neoplasms, Endometrial Neoplasms, Hepatoblastoma, Desmoid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡